Dr. Antoin Douglawi, MD

Dr. Douglawi practices at Arrowhead Regional Medical Center in Colton, California, part of San Bernardino County.

Dr. Douglawi's NPI, 1215317847, was assigned on June 9, 2015. Dr. Douglawi graduated from Keck School of Medicine of USC in 2015. Dr. Douglawi holds California license A168501.

Dr. Douglawi's primary practice is Arrowhead Regional Medical Center, at 400 North Pepper Avenue, Colton, CA 92324 in San Bernardino County. The practice phone is (909) 580-1000.

Dr. Douglawi's primary practice is Arrowhead Regional Medical Center in Colton, California, part of San Bernardino County. Dr. Douglawi is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Douglawi to 3 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Douglawi practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Douglawi's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Douglawi is board certified in urology by the American Board of Urology. Dmand AI has Dr. Douglawi's licenses on file in 2 states: California and Indiana.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Douglawi treats.

CMS data shows 372 Medicare services from Dr. Douglawi across 9 procedure codes in 2024, for 248 Medicare patients. Medicare paid $47,497 for them.

CMS counts 248 Medicare patients who saw Dr. Douglawi in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Douglawi's median patient age at 65, with 28% women.

In 2024, Dr. Douglawi wrote 337 Medicare Part D claims for 135 patients. 97% of them were for generic drugs. CMS names the drug for 258 of them, across 4 drugs with 11 or more claims each, at $2,979 in total drug cost. In 2023, CMS named 220 claims across 5 drugs.

Dr. Douglawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Douglawi as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Douglawi, published from 2017 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Urinary Bladder Neoplasms, Carcinoma, Transitional Cell and Nephroureterectomy. Dr. Douglawi's most frequent co-authors are Daniel D. Eun, MD, Chandru P. Sundaram, MD and Robert Guy Uzzo, MD.

CMS Open Payments shows 13 general payments to Dr. Douglawi from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Urogen Pharma, Inc. paid the most, $361.

Dr. Douglawi graduated from Keck School of Medicine of USC in 2015.

Dr. Douglawi is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.